These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1693037)

  • 1. [Effects of anti-androgens on sexual function. Double-blind comparative studies on allylestrenol and chlormadinone acetate Part I: Nocturnal penile tumescence monitoring].
    Kumamoto Y; Yamaguchi Y; Sato Y; Suzuki R; Tanda H; Kato S; Mori K; Matsumoto H; Maki A; Kadono M
    Hinyokika Kiyo; 1990 Feb; 36(2):213-26. PubMed ID: 1693037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of anti-androgens on sexual function. Double-blind comparative studies on allylestrenol and chlormadinone acetate. Part II: Self-assessment questionnaire method].
    Kumamoto Y; Yamaguchi Y; Sato Y; Suzuki R; Tanda H; Kato S; Mori K; Matsumoto H; Maki A; Kadono M
    Hinyokika Kiyo; 1990 Feb; 36(2):227-44. PubMed ID: 1693038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical effects of allylestrenol on benign prostatic hypertrophy by double-blind method].
    Shida K; Koyanagi T; Kawakura K; Nishida T; Kumamoto Y; Orikasa S; Sato S; Takeda M; Yamanaka H; Shimazaki J
    Hinyokika Kiyo; 1986 Apr; 32(4):625-48. PubMed ID: 2426932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized phase II trial of flutamide vs chlormadinone acetate in previously untreated advanced prostatic cancer. The Japan Flutamide Study Group.
    Akaza H; Usami M; Kotake T; Koiso K; Aso Y
    Jpn J Clin Oncol; 1993 Jun; 23(3):178-85. PubMed ID: 7688829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fundamental and clinical study of the anti-prostatic effect of allylestrenol].
    Yamanaka H; Kosaku N; Makino T; Shida K
    Hinyokika Kiyo; 1983 Sep; 29(9):1133-45. PubMed ID: 6203385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The preventive effect of indeloxazine hydrochloride to the sexual dysfunction caused by anti-androgenergic agent (allylestrenol)].
    Horita H; Kumamoto Y; Satoh Y; Suzuki N; Wada H; Shibuya A; Adachi H; Kurohata T; Tsukamoto T
    Nihon Hinyokika Gakkai Zasshi; 1995 May; 86(5):1044-50. PubMed ID: 7541089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical effects of allylestrenol on prostatic hypertrophy].
    Kohri K; Kurita T; Iguchi M; Kataoka K
    Hinyokika Kiyo; 1986 Mar; 32(3):486-92. PubMed ID: 2425611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical studies on morphological changes in the prostate in patients with benign prostatic hypertrophy after antiandrogen therapy--by means of transrectal ultrasonotomography].
    Suzuki K; Ichinose Y; Hashimoto K; Matsumoto K; Suzuki T; Imai K; Yamanaka H
    Hinyokika Kiyo; 1990 May; 36(5):557-60. PubMed ID: 1698012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of Cernilton on benign prostatic hypertrophy--a multiple center double-blind study with Paraprost].
    Maekawa M; Kishimoto T; Yasumoto R; Wada S; Harada T; Ohara T; Okajima E; Hirao Y; Ohzono S; Shimada K
    Hinyokika Kiyo; 1990 Apr; 36(4):495-516. PubMed ID: 1696065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study of allylestrenol (Org AL-25) on patients with prostatic hypertrophy--transrectal ultrasonography and urodynamic examination].
    Ohyama M; Tanifuji T; Haraguchi C; Fujii N; Higaki Y; Yoshida H; Imamura K
    Hinyokika Kiyo; 1986 Apr; 32(4):649-59. PubMed ID: 2426933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study of allylestrenol (Perselin) on patients with prostatic hypertrophy].
    Fukuoka H; Ishibashi Y; Shiba T; Tuchiya F; Sakanishi S
    Hinyokika Kiyo; 1993 Jul; 39(7):679-83. PubMed ID: 7689782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of CMA in the treatment of prostatic cancer].
    Fukuoka H; Goto A; Murai T; Satomi Y; Moriyama M; Senga Y; Shirai K; Nakao H
    Hinyokika Kiyo; 1986 Dec; 32(12):1821-30. PubMed ID: 2435131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical effect of allylestrenol on benign prostatic hypertrophy].
    Tajima A; Aso Y; Ushiyama T; Hata M; Kambayashi T; Ohmi Y; Masuda H; Nakahara M; Kitagawa M; Suzuki A
    Hinyokika Kiyo; 1986 Mar; 32(3):477-85. PubMed ID: 2425610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen changes as a result of chlormadinone acetate administration to patients with benign prostatic hyperplasia: a retrospective multi-institutional study.
    Fujimoto K; Hirao Y; Masumori N; Arai Y; Yamanaka H; Kato T; Miyazawa K
    Int J Urol; 2006 May; 13(5):543-9. PubMed ID: 16771723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between sleep-related erections and testosterone levels in men.
    Granata AR; Rochira V; Lerchl A; Marrama P; Carani C
    J Androl; 1997; 18(5):522-7. PubMed ID: 9349750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pretreatment with chlormadinone acetate in prostate cancer patients treated with a luteinizing hormone-releasing hormone analogue].
    Yamamoto A; Sumiyoshi Y; Miyake N; Yokozeki H; Kanayama H; Kagawa S
    Hinyokika Kiyo; 1998 Aug; 44(8):557-63. PubMed ID: 9783191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of combination therapy with a luteinizing hormone-releasing hormone agonist and chlormadinone acetate on rat prostate weight and plasma testosterone levels.
    Gotanda K; Shinbo A; Okada M; Nakano Y; Kobayashi H; Sasaki T; Hagiwara M; Akaza H
    Prostate Cancer Prostatic Dis; 2003; 6(1):66-72. PubMed ID: 12664069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hormonal environment following treatment with a small dose of estrogen--small dose of estrogen alone and in combination with an anti-androgen].
    Hayashi T; Taki Y; Ikai K; Hiura M; Kiriyama T
    Hinyokika Kiyo; 1987 Jul; 33(7):1035-42. PubMed ID: 2446483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of chlormadinone acetate-pellet implantation and orchidectomy on benign prostatic hypertrophy in the dog.
    Kawakami E; Tsutsui T; Shimizu M; Orima H; Fujita M; Ogasa A
    Int J Androl; 1995 Oct; 18(5):248-55. PubMed ID: 8567095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Doxazosin in the gastrointestinal therapeutic system (GITS) and doxazosin standard in patients with benign prostatic hyperplasia. Double-blind trial of efficacy and tolerability].
    Gratzke P; Kirby RS
    Fortschr Med Orig; 2000 Jul; 118 Suppl 2():83-92. PubMed ID: 15700491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.